OBSTETRICS
Ten-Year, Thirty-Year, and Lifetime Cardiovascular Disease Risk Estimates Following a Pregnancy Complicated by Preeclampsia

https://doi.org/10.1016/S1701-2163(16)35381-6Get rights and content

Abstract

Objectives

To calculate the cardiovascular disease (CVD) risk estimates for women following a pregnancy with or without preeclampsia.

Methods

We calculated 10-year, 30-year, and lifetime CVD risk estimates at one year postpartum for women recruited into the Pre-Eclampsia New Emerging Team’s prospective cohort.

Results

Complete CVD risk screening data were obtained from 118 control women and 99 preeclamptic women. A total of 18.2% of preeclamptic women and 1.7% of control women had a high 10-year risk (OR 13.08; 95% CI 3.38 to 85.5), 31.3% of preeclamptic women and 5.1% of control women had a high 30-year risk (OR 8.43; 95% CI 3.48 to 23.23), and 41.4% of preeclamptic women and 17.8% of control women had a high lifetime risk for CVD (OR 3.25; 95% CI 1.76 to 6.11).

Conclusion

The association of preeclampsia with the future development of CVD makes pregnancy an early window of opportunity for the preservation of health and prevention of CVD.

Résumé

Objectif

Calculer les estimations du risque de maladie cardiovasculaire (MCV) chez les femmes à la suite d’une grossesse s’étant accompagnée ou non d’une prééclampsie.

Méthodes

Nous avons calculé des estimations du risque de MCV sur 10 ans, sur 30 ans et à vie à un an postpartum pour ce qui est des femmes ayant participé à la cohorte prospective Pre-Eclampsia New Emerging Team.

Résultats

Des données complètes sur le dépistage du risque de MCV ont été obtenues auprès de 118 témoins et de 99 femmes prééclamptiques. Au total, 18,2 % des femmes prééclamptiques et 1,7 % des témoins étaient exposées à un risque élevé de MCV sur 10 ans (RC, 13,08; IC à 95 %, 3,38 - 85,5), 31,3 % des femmes prééclamptiques et 5,1 % des témoins étaient exposées à un risque élevé de MCV sur 30 ans (RC, 8,43; IC à 95 %, 3,48 - 23,23), et 41,4 % des femmes prééclamptiques et 17,8 % des témoins étaient exposées à un risque élevé de MCV à vie (RC, 3,25; IC à 95 %, 1,76 - 6,11).

Conclusions

L’association entre la prééclampsie et l’apparition future d’une MCV fait en sorte que la grossesse constitue une période précocement très propice à la mise en oeuvre de mesures visant le maintien de la santé et la prévention de la MCV.

REFERENCES (18)

There are more references available in the full text version of this article.

Cited by (84)

  • Effects of pre-eclampsia on HDL-mediated cholesterol efflux capacity after pregnancy

    2022, Atherosclerosis Plus
    Citation Excerpt :

    Women with a history of preeclampsia (PE) have a long-term increased risk of cardiovascular disease (CVD) compared to women who had a normotensive pregnancy [1–3]. Meta-analysis and cohort studies indicate that this risk is increased 2-fold and is evident within 10 years after pregnancy, i.e. still at an early stage in life, interacts with established risk factors, and lasts a lifetime [1,4–7]. Women who have experienced PE also show an increased incidence of hypertension, diabetes and dyslipidemia, all thought to contribute to the increased risk of CVD.

  • Arterial stiffness and pulsatile hemodynamics in pregnancy and pregnancy-related vascular complications

    2022, Textbook of Arterial Stiffness and Pulsatile Hemodynamics in Health and Disease
View all citing articles on Scopus

Competing Interests: None declared.

Parts of this data were presented at the Society for Maternal–Fetal Medicine (2012) and Society for Gynecologic Investigation (2012).

View full text